How to use the speech recognition tool?



A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).

Type: Observational

Status of the trial: Completed

Orphan Drug Recognition: NA


  • Opening Date: 2016-09-01
  • Closing Date: 2021-02-01


Inclusion: Patient prescribed Raxone® for the treatment of LHON; Patient has completed an Informed Consent Form (ICF) indicating that he/ she (or a legally acceptable representative) has been informed of all pertinent aspects of the study and has agreed to participa

Exclusion: No explicit exclusion criteria exist to avoid selection bias and to allow for documentation of routine clinical practice.

More information

Children: No

Adults: No

Funder Type: industry

HCP: Other investigators

Within ERN-EYE members

Principal investigators

Other investigators


  • Neuro-Ophthalmology Rare Diseases (WG2)


* indicates required

This ERN is supported by: